Vascular Drugs
71 drugs
- Alirocumab (PCSK9 Inhibitor — Post-ACS)PCSK9 Inhibitor (Human Monoclonal Antibody)
- Alprostadil (PGE1)Prostaglandin E1
- Alteplase (Peripheral Arterial / DVT Use)Thrombolytic — Catheter-Directed Thrombolysis / Peripheral Arterial Occlusion
- AmbrisentanSelective Endothelin-A Receptor Antagonist — Pulmonary Arterial Hypertension
- Aminocaproic AcidAntifibrinolytic — Surgical Haemostasis (Alternative to Tranexamic Acid)
- AmlodipineDihydropyridine Calcium Channel Blocker — Raynaud's / Peripheral Vascular Disease / Hypertension
- ApixabanDirect Oral Factor Xa Inhibitor — VTE / AF Stroke Prevention
- ArgatrobanDirect Thrombin Inhibitor — HIT
- Aspirin (Antiplatelet)Antiplatelet — COX Inhibitor
- AtorvastatinHMG-CoA Reductase Inhibitor (Statin)
- Betrixaban (Extended VTE Prophylaxis — Medical Patients)Oral Factor Xa Inhibitor (DOAC — Extended Duration)
- BivalirudinDirect Thrombin Inhibitor — HIT / Endovascular Procedures
- BosentanEndothelin Receptor Antagonist (ERA) — Pulmonary Arterial Hypertension / Digital Ulcers
- Canakinumab (IL-1β Inhibitor — Post-MI CV Prevention)IL-1β Monoclonal Antibody (Anti-Inflammatory CV Agent)
- Cangrelor (IV P2Y12 Inhibitor — Acute PCI)Intravenous P2Y12 ADP Receptor Antagonist (Direct-Acting, Reversible)
- CilostazolPhosphodiesterase type 3 inhibitor / antiplatelet
- CilostazolPhosphodiesterase-3 Inhibitor (Antiplatelet/Vasodilator)
- ClopidogrelAntiplatelet (P2Y12 ADP receptor antagonist)
- Colchicine (Cardiovascular Anti-Inflammatory)Anti-Inflammatory — NLRP3 Inflammasome Inhibitor (Cardiovascular Indication)
- DabigatranDirect Oral Thrombin Inhibitor — VTE / AF Stroke Prevention
- DalteparinLow Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
- Desmopressin (DDAVP)Vasopressin Analogue — Haemostasis / Haemophilia A / vWD
- Dipyridamole (Secondary Stroke Prevention)Antiplatelet — Phosphodiesterase Inhibitor / Adenosine Uptake Inhibitor
- DoxazosinAlpha-1 Adrenoceptor Antagonist — Hypertension / Raynaud's / BPH
- Edoxaban (VTE Treatment/PE — Vascular)Direct Factor Xa Inhibitor (DOAC)
- Enoxaparin (Vascular)Low Molecular Weight Heparin
- EpoprostenolProstacyclin (PGI2) — Severe Pulmonary Arterial Hypertension
- Eptifibatide (GPIIb/IIIa Inhibitor — ACS/PCI)GPIIb/IIIa Receptor Antagonist (Cyclic Peptide)
- FondaparinuxIndirect Factor Xa Inhibitor — VTE Prophylaxis / Treatment
- Glyceryl Trinitrate (IV)Organic Nitrate (IV)
- HydralazineDirect-Acting Vasodilator — Hypertensive Emergency / Chronic Hypertension
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction)Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Iloprost (IV/Inhaled)Prostacyclin Analogue
- Iloprost (IV/Nebulised)Prostacyclin analogue (vasodilator)
- Inositol nicotinatePeripheral vasodilator
- Isosorbide MononitrateOrganic Nitrate
- LosartanAngiotensin II Receptor Blocker (ARB) — Hypertension / Raynaud's / Marfan Syndrome
- MacitentanEndothelin Receptor Antagonist (ERA) — Pulmonary Arterial Hypertension
- Naftidrofuryl oxalateVasodilator
- Naftidrofuryl Oxalate5-HT2 Receptor Antagonist — Peripheral Arterial Disease (Intermittent Claudication)
- Nifedipine (Modified-release)Dihydropyridine calcium channel blocker
- Nifedipine (Raynaud's)Calcium Channel Blocker (Dihydropyridine)
- OxerutinsBioflavonoid (rutin)
- PentoxifyllineHemorheological Agent (Methylxanthine)
- Pentoxifylline (Oxpentifylline)Haemorrheological agent (xanthine derivative)
- PhenoxybenzamineIrreversible Non-Selective Alpha Adrenoceptor Antagonist — Phaeochromocytoma Pre-operative Preparation
- PhentolamineNon-Selective Alpha Adrenoceptor Antagonist — Vasopressor Extravasation / Phaeochromocytoma
- Prasugrel (P2Y12 Antiplatelet — ACS/PCI)P2Y12 ADP Receptor Antagonist (Thienopyridine Prodrug)
- PrazosinAlpha-1 Adrenoceptor Antagonist — Raynaud's Phenomenon / Hypertension
- Protamine SulphateHeparin Antidote — Vascular / Cardiac Surgery
- RamiprilACE Inhibitor
- RiociguatSoluble Guanylate Cyclase (sGC) Stimulator — PAH / CTEPH
- RivaroxabanDirect Oral Factor Xa Inhibitor — VTE / PAD / AF Stroke Prevention
- SelexipagProstacyclin Receptor (IP Receptor) Agonist — Pulmonary Arterial Hypertension
- SildenafilPDE5 Inhibitor — Pulmonary Arterial Hypertension / Raynaud's Phenomenon
- Sodium NitroprussideDirect Vasodilator (NO Donor) — Hypertensive Emergency / Aortic Dissection
- Sodium tetradecyl sulfateSclerosant
- StreptokinaseThrombolytic — Peripheral Arterial Occlusion / DVT (Historical)
- Tenecteplase (TNK-tPA — STEMI/Massive PE)Fibrin-Specific Thrombolytic (Third-Generation tPA)
- TerlipressinVasopressin analogue / vasopressor
- Terlipressin (Vascular)Vasopressin Analogue
- TicagrelorAntiplatelet (reversible P2Y12 inhibitor)
- TinzaparinLow Molecular Weight Heparin — VTE Treatment / Prophylaxis
- Tirofiban (GPIIb/IIIa Inhibitor — ACS/PCI)GPIIb/IIIa Receptor Antagonist (Non-Peptide Mimetic)
- Tranexamic AcidAntifibrinolytic — Vascular / Surgical Haemostasis
- TreprostinilProstacyclin Analogue — Pulmonary Arterial Hypertension / Digital Ulcers
- Unfractionated Heparin (IV)Anticoagulant — Indirect Thrombin Inhibitor
- Unfractionated Heparin (Peripheral/Central Line Flush)Anticoagulant flush / catheter maintenance
- UrokinaseThrombolytic — Catheter-Directed Thrombolysis / Catheter Occlusion
- VorapaxarPAR-1 (Protease-Activated Receptor-1) Antagonist — Secondary Prevention in PAD / MI
- WarfarinVitamin K Antagonist